EQL Pharma AB (FRA:7JK) Long-Term Debt : €1.48 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB Long-Term Debt?

EQL Pharma AB's Long-Term Debt for the quarter that ended in Mar. 2024 was €1.48 Mil.

EQL Pharma AB's quarterly Long-Term Debt stayed the same from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€0.00 Mil) but then increased from Dec. 2023 (€0.00 Mil) to Mar. 2024 (€1.48 Mil).

EQL Pharma AB's annual Long-Term Debt declined from Mar. 2022 (€0.68 Mil) to Mar. 2023 (€0.00 Mil) but then increased from Mar. 2023 (€0.00 Mil) to Mar. 2024 (€1.48 Mil).

EQL Pharma AB Long-Term Debt Historical Data

The historical data trend for EQL Pharma AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Long-Term Debt Chart

EQL Pharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

Get a 7-Day Free Trial

1.24

0.68

1.48

EQL Pharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	-	1.48

EQL Pharma AB (FRA:7JK) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

EQL Pharma AB Long-Term Debt Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

EQL Pharma AB (FRA:7JK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

EQL:Sweden

Address

Stortorget 1, 3rd Floor, Lund, SWE, 222 23

Website

http://www.eqlpharma.com

EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines